drugset / Trial / NCT00536666
A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety profile of iron oligosaccharide in patients with chronic kidney disease with a need for parenteral iron.
Timeline
- Start
- 2007-05
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iron isomaltoside 1000 | Unknown | — | Intravenous |